{"id":"W3031554237","doi":"10.1016/j.jaad.2020.05.105","title":"Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"UCB","keywords":"Medicine; Double blinded; Placebo; Plaque psoriasis; Randomized controlled trial; Blinded study; Dermatology; Psoriasis; Physical therapy; Surgery; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00187114,0.001606129,0.003237084,0.0004161129,0.0004845666,0.001170964,0.0007592646,0.001827706,0.005452625],"category_scores_gemma":[0.001321792,0.0006989624,0.002175554,0.0003040922,0.0007198395,0.00105807,0.0003908005,0.003019162,0.001115556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004374616,"about_ca_system_score_gemma":0.0008090282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008343355,"about_ca_topic_score_gemma":0.001502036,"domain_scores_codex":[0.9994907,0.0002128189,0.0000311729,0.00008539855,0.00005960046,0.0001201766],"domain_scores_gemma":[0.9993956,0.0001428551,0.0001263701,0.00006406043,0.00004405031,0.0002270152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9464223,0.01085813,0.0008968081,0.0009566738,0.001080174,0.0000650557,0.00008011983,0.000331844,0.007891603,0.00008322655,0.001970123,0.02936398],"study_design_scores_gemma":[0.9545789,0.03945963,0.004030524,0.00003448111,0.0004377723,0.00004243591,0.00001922046,0.0001775641,0.0004049752,0.00008734322,0.0007123194,0.00001482413],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818748,0.00936859,0.0007028744,0.0008625841,0.0005139962,0.001867183,0.001780684,0.0002073008,0.002822089],"genre_scores_gemma":[0.9808877,0.005438094,0.001606918,0.002137568,0.0006562812,0.002147114,0.001992576,0.00006174515,0.005072013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005452625,"threshold_uncertainty_score":0.01824087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03360327941764896,"score_gpt":0.2916476084855545,"score_spread":0.2580443290679055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}